Asra Al Fauzi, Asra Al Fauzi and Purwati, Purwati and Nur Setiawan Suroto, Nur Setiawan Suroto and Muhammad Arifin Parenrengi, Muhammad Arifin Parenrengi and Joni Wahyuhadi, Joni Wahyuhadi and Agus Turchan, Agus Turchan and Ferdiansyah Mahyudin, Ferdiansyah Mahyudin and Heri Suroto, Heri Suroto and Fedik Abdul Rantam, Fedik Abdul Rantam and Mochammad Hasan Machfoed, Mochammad Hasan Machfoed and Abdul Hafid Bajamal, Abdul Hafid Bajamal and Christianto Benjamin Lumenta, Christianto Benjamin Lumenta (2017) Clinical Outcomes of Repeated Intraventricular Transplantation of Autologous Bone Marrow Mesenchymal Stem Cells in Chronic Haemorrhagic Stroke. A One-Year Follow Up. The Open Neurology Journal, 11. ISSN 1874-205X

	Text (ARTIKEL) 13. clinical outcomes of repeated intraventricular transplantation of autologous bone marrow mesenchymal stem cells in chro.pdf Download (423kB)
	Text (SIMILARITY) 13. clinical outcomes of repeated intraventricular transplantation of autologous bone marrow mesenchymal stem cells in chronic haemorrhagic stroke. A one year follow up.pdf Download (2MB)
	Text (REVIEWER) 13. PEER_REVIEWER clinical outcomes of repeated intraventricular transplantation of autologous bone marrow mesenchymal stem cells in chroni..pdf Download (3MB)
	Text (KESESUAIAN BIDANG ILMU) 14. Clinical Outcomes of Repeated Intraventricular Transplantation o.pdf Download (377kB)

Abstract

Object: Stroke, one of the most devastating diseases, is a leading cause of death and disability throughout the world and is also associated with emotional and economic problems. The main goal of this study was to investigate the clinical outcome of the intraventricular transplantation of bone marrow mesenchymal stem cells (BM-MSCs) in post-haemorrhagic stroke patients. Method: This study was done consisting of eight patients with supratentorial haemorrhagic stroke, who had undergone 24 weeks of standard treatment of stroke with stable neurological deficits. All of the patients received stem cell transplantation intraventricularly using autologous BM-MSCs. Six months and Twelve months after stem cells treatment, the clinical outcomes were measured using the National Institute of Health Stroke Scale (NIHSS) and adverse effect also observed. Result: The results of this study showed improvement of NIHSS score values before and after the treatment in five patients. No adverse effects or complications were detected during the 1-year observation. Conclusion: Intraventricular transplantation of BM-MSCs has shown benefits in improving the functional status of post-haemorrhagic stroke patients with no adverse effect.

Actions (login required)

View Item